Rotational activity ablation added to PVI shows 91.5% sinus rhythm in persistent AF cohort
This prospective multicenter cohort study evaluated 76 patients with persistent atrial fibrillation (AF) who received ablation of rotational activity (RotAct) on top of pulmonary vein isolation (PVI), compared to 56 control patients receiving a standard ablation protocol. The primary outcome was maintenance of sinus rhythm during a mean follow-up of 13 ± 6 months. RotAct was identified in 29 patients (38%) at initial mapping. PVI significantly modified the number and localization of RotActs, with disappearance in 18 patients and new appearance in 5 patients (p=0.012).
At follow-up, 91.5% of patients in the RotAct ablation group were in stable sinus rhythm, compared to 78.6% in the control group (p=0.025). The study reports this as a significant reduction in relapse for the tailored ablation strategy. Safety and tolerability data, including adverse events and discontinuations, were not reported.
Key limitations include the observational cohort design, which cannot establish causality, and the lack of reported safety data. The sample size was modest, and follow-up duration was intermediate. Funding sources and author conflicts of interest were not reported. The practice relevance is that a tailored ablation strategy targeting RotAct in addition to PVI was associated with a high procedural success rate in this specific cohort, but these findings are preliminary and require validation in randomized controlled trials before clinical adoption can be considered.